The Safety and Efficacy of Cerebrolysin in Patients With Acute Ischemic Stroke
Clinical trial NCT00868283 · COMPLETED
Trial details
- NCT number
- NCT00868283
- Sponsor
- Ever Neuro Pharma GmbH
- Status
- COMPLETED
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Start date
- 2006-09-01
- Primary completion
- 2010-10-01
- Enrollment
- 1071
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.